Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Nervous System Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002621
What this trial is testing

Interferon Alfa in Treating Children With HIV-Related Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 8
Not applicableStudy completedNCT02652715
What this trial is testing

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more
Mayo Clinic 29
Testing effectiveness (Phase 2)Looking for participantsNCT06556199
What this trial is testing

Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma

Who this might be right for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 38
Post-approval studies (Phase 4)UnknownNCT02347878
What this trial is testing

Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)

Who this might be right for
LeukemiaLymphoma
Sun Yat-sen University 85
Not applicableStudy completedNCT00226304
What this trial is testing

Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma

Who this might be right for
HIV InfectionsLymphoma, AIDS-Related
National Institutes of Health Clinical Center (CC) 120
Testing effectiveness (Phase 2)UnknownNCT01735747
What this trial is testing

Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma

Who this might be right for
Central Nervous System Tumors
Rongjie Tao 16
Not applicableAvailableNCT05974410
What this trial is testing

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Who this might be right for
GlioblastomaSquamous Cell CarcinomaHodgkin Lymphoma+14 more
AVM Biotechnology Inc
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Study completedNCT01421524
What this trial is testing

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more
Celgene 271
Not applicableUnknownNCT04828434
What this trial is testing

Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study

Who this might be right for
DementiaDementia, VascularDementia, Mixed+8 more
University College, London 34
Not applicableStudy completedNCT00920738
What this trial is testing

Metabolic Syndrome in Childhood Cancer Survivors

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+2 more
University of Minnesota 512
Not applicableLooking for participantsNCT05841914
What this trial is testing

Multicentre Implementation and Validation of a Molecular Diagnostic for VitreoRetinal Lymphoma

Who this might be right for
Vitreoretinal Lymphoma
Vinodh Kakkassery, MD 220
Not applicableUnknownNCT05117814
What this trial is testing

Zanubrutinib Monotherapy in Relapsed/Refractory Central Nervous System Lymphoma

Who this might be right for
CNS Lymphoma
Peking University People's Hospital 20
Post-approval studies (Phase 4)Study completedNCT01373983
What this trial is testing

Intrathecal Bolus Doses of Ziconotide

Who this might be right for
Peripheral Neuropathy
University Hospital, Linkoeping 26
Not applicableStudy completedNCT07673666
What this trial is testing

GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3)

Who this might be right for
GliomaGlioma (Diagnosis)Astrocytoma+4 more
Deep Learning Institute of Radiological Sciences 1,372
Not applicableWithdrawnNCT05169151
What this trial is testing

Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study

Who this might be right for
Central Nervous System NeoplasmHodgkin LymphomaMalignant Solid Neoplasm+2 more
M.D. Anderson Cancer Center
Not applicableLooking for participantsNCT06292741
What this trial is testing

Autonomic Involvement in Patient With Cognitive Decline

Who this might be right for
Dementia, MildDementia of Alzheimer Type
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Ended earlyNCT05242146
What this trial is testing

GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma

Who this might be right for
CNS Lymphoma
GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT02301364
What this trial is testing

Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Who this might be right for
LymphomaPrimary Central Nervous System LymphomaRecurrent/Refractory Secondary Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer Center 4
Next Page